Table 1.
PRC1 staining and clinicopathological characteristics of 103 hepatocellular carcinoma patients.
| PRC1 | ||||
|---|---|---|---|---|
| Parameters | Low (%) | High (%) | Total | P-value |
| Age (years old) | 0.114 | |||
| <50 | 17 (16.5) | 31 (30.1) | 48 | |
| ≥50 | 28 (27.2) | 27 (26.2) | 55 | |
| Gender | 0.793 | |||
| Female | 19 (17.2) | 23 (24.7) | 42 | |
| Male | 26 (25.2) | 35 (34.0) | 61 | |
| Postoperative chemotherapy | 0.071 | |||
| No | 29 (28.2) | 27 (26.2) | 56 | |
| Yes | 16 (15.5) | 31 (30.1) | 47 | |
| TNM stage | 0.018* | |||
| I | 19 (18.4) | 11 (10.7) | 30 | |
| II | 16 (15.5) | 22 (21.4) | 38 | |
| III | 10 (9.7) | 25 (24.3) | 35 | |
*
p < 0.05, chi-square test.